Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout
Tilray Brands (TLRY) is back at the center of the cannabis market’s biggest catalyst in years: growing expectations that President Donald Trump could move to ease federal marijuana restrictions by pushing a reclassification of cannabis to Schedule III. On Monday,